Keyword Search Year None 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 Nov 04, 2026 Labcorp Completes Acquisition of Millennium Health Read more » Nov 04, 2026 Labcorp to Speak at the UBS Global Healthcare Conference Read more » Oct 28, 2026 Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance Read more » Oct 23, 2026 Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026 Read more » Oct 23, 2026 Labcorp Announces Definitive Agreement to Acquire Millennium Health Read more » Oct 22, 2026 Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential Read more » Oct 21, 2026 Labcorp Declares Quarterly Dividend Read more » Oct 20, 2026 Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp Read more » Oct 15, 2026 Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health Read more » Oct 13, 2026 Labcorp and Arianna Huffington's Thrive Global Collaborate to Launch Thrive 5 Health Test Read more » Sep 30, 2026 Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026 Read more » Sep 10, 2026 Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day Read more » Sep 08, 2026 Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials Read more » Aug 31, 2026 Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity Read more » Aug 28, 2026 Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference Read more » Aug 24, 2026 Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings Read more » Aug 18, 2026 Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health Read more » Aug 17, 2026 Labcorp to Host Investor Day on September 10, 2026 Read more » Aug 10, 2026 Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma Read more » Aug 04, 2026 Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer Read more » Jul 30, 2026 Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance Read more » Jul 27, 2026 Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing Read more » Jul 09, 2026 Labcorp Declares Quarterly Dividend Read more » Jun 30, 2026 Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026 Read more » Jun 22, 2026 Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test Read more » Current page 1 Page 2 Next page next › Last page last »
